$ACON News

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site

Aclarion Announces University Of Arizona College Of Medicine - Phoenix As New Clinical Site In Its CLARITY Trial

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Aclarion Says USPTO Issues Notice Of Allowance For U.S. Patent Application Titled Multi-Voxel Prescription For Lumbar Disc Evaluation

Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Aclarion Announces Texas Spine Care Center as New CLARITY Site

Aclarion Announces Texas Spine Care Center As New Clinical Site In Chronic Low bAck pain Randomized Independent Trial studY Trial

Aclarion Receives Notice Of Allowance For A U.S. Patent On Its Multi-Voxel Prescription For Lumbar Disc Evaluation

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Launches Market Access Program In Partnership With PRIA Healthcare

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Board Reviews Echo Lake's Unsolicited Public Proposal And Unanimously Determined To Reject It

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Partners With Institute of Neuro Innovation on Back Pain Technology

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study